The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

Share Price Information for Idox Group (IDOX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 65.00
Bid: 63.20
Ask: 65.40
Change: 0.80 (1.25%)
Spread: 2.20 (3.481%)
Open: 63.20
High: 65.00
Low: 63.20
Prev. Close: 64.20
IDOX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Year End Trading Update

25 Nov 2019 07:00

RNS Number : 4360U
IDOX PLC
25 November 2019
 

25 November 2019

Idox plc

('Idox' or the 'Group' or the 'Company')

Year End Trading Update

 

ldox plc (AIM: IDOX), a leading supplier of specialist information management solutions and services, today is pleased to issue a trading update for its financial year ended 31 October 2019. 

The Group continues to make good strategic and commercial progress across the business and expects to report results in line with the Board's expectations:

·; revenues of £66.0m (2018: £67.4m).

·; revenue visibility significantly improved, with annualised recurring revenue run rate at 31 October 2019 up 20% to £38.9m following adoption of IFRS 15 (16% organic)

·; contracted software and services order book up 29% to £12.1m.

·; adjusted EBITDA† £14.4m (2018: £14.4m).

·; net debt at 31 October 2019 down 17% at £26.4m (2018: £31.8m).

·; statutory profit before tax of £0.3m (2018: loss of £27.0m) for continuing operations.

The Group has made significant progress over the last year following the appointment of a new Board, new senior management and finance teams, with improved accounting practises, enhanced employee, customer and shareholder engagement, and full integration of prior period acquisitions. Idox continues to be focused on its core of Public Sector software, supported by our valuable Content and Engineering divisions.

Sustaining and improving levels of recurring revenues remains a priority as the Group's products transition to cloud-based technologies. The acquisition of Tascomi completed in August 2019, enhances the Group's technological capabilities and market leading positions as well as building the recurring SaaS revenue profile. Tascomi is being integrated into the Group and is performing to plan.

Further to the update provided in the half year results, we anticipate announcing new multi-year committed borrowing facilities prior to our FY2019 results announcement.

The Group expects to issue its FY2019 results announcement in early February 2020.

Adjusted EBITDA is defined as earnings before amortisation, depreciation, restructuring, acquisition, corporate finance and share option costs.

 

David Meaden, Chief Executive of Idox, commented:

"Our 2019 financial year has seen extensive and positive changes throughout the business as we have re-established how we organise, measure and run operations across the Group.

"We continue to focus on driving full value from the Group's assets and working intelligently to drive high margin and cash generation. 

"I am excited by the team we have assembled, and the opportunities presented to us to build value for our employees, customers and stakeholders. We remain excited and confident in the ongoing prospects for the Group."

 

-Ends-

This announcement is released by Idox plc and contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 ("MAR"), encompassing information relating to the trading update described herein, and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

Enquiries:

Idox plc

+44 (0) 870 333 7101

David Meaden, Chief Executive

Rob Grubb, Chief Financial Officer

N+1 Singer (NOMAD and Broker)

+44 (0) 20 7496 3000

Shaun Dobson / Ben Farrow (Corporate Finance)

Tom Salvesen (Corporate Broking)

 

 

About Idox plc

For more information see www.idoxplc.com @Idoxgroup 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTUUABRKVAAUAA
Date   Source Headline
24th Apr 20247:00 amRNSReplacement: Total Voting Rights
17th Apr 202412:43 pmRNSTotal Voting Rights
28th Mar 20245:22 pmRNSHolding(s) in Company
28th Mar 202412:37 pmRNSDirector/PDMR Shareholding
28th Mar 202411:21 amRNSResult of AGM
28th Mar 20247:00 amRNSAGM Trading update
22nd Mar 20245:42 pmRNSDirector/PDMR Shareholding
18th Mar 20247:00 amRNSTotal Voting Rights
11th Mar 20248:40 amRNSHolding(s) in Company
8th Mar 20247:00 amRNSDirector/PDMR Shareholding
5th Mar 20245:12 pmRNSPosting of Annual Report and Notice of AGM
14th Feb 20241:39 pmRNSHolding(s) in Company
9th Feb 20247:00 amRNSExercise of Share Options & Total Voting Rights
25th Jan 20247:00 amRNSFinal Results
18th Jan 202412:35 pmRNSNotice of Final Results
17th Jan 20247:00 amRNSExercise of Share Options & Total Voting Rights
27th Nov 20237:00 amRNSHolding(s) in Company
22nd Nov 20237:00 amRNSYear End Trading Update
9th Nov 202310:25 amRNSHolding(s) in Company
6th Nov 20233:01 pmRNSHolding(s) in Company
2nd Nov 20232:10 pmRNSHolding(s) in Company
2nd Nov 202310:09 amRNSHolding(s) in Company
1st Nov 202311:48 amRNSHolding(s) in Company
18th Oct 20237:00 amRNSAdoption of New LTIP and Grant of Options
4th Oct 20237:00 amRNSExercise of Share Options & Total Voting Rights
25th Sep 202310:06 amRNSHolding(s) in Company
11th Sep 20237:00 amRNSExercise of Share Options & Total Voting Rights
31st Aug 20237:00 amRNSExercise of Share Options & Total Voting Rights
21st Aug 20237:00 amRNSAcquisition
4th Aug 20237:00 amRNSExercise of Share Options & Total Voting Rights
3rd Aug 20231:49 pmRNSHolding(s) in Company
1st Aug 20237:00 amRNSChange of Registered Address
14th Jul 20237:00 amRNSExercise of Share Options & Total Voting Rights
27th Jun 20237:00 amRNSExercise of Share Options & Total Voting Rights
13th Jun 20237:00 amRNSPayment of Earnout and Allotment of Shares
12th Jun 20234:44 pmRNSHolding(s) in Company
8th Jun 20237:00 amRNSHalf Year results
18th May 20237:00 amRNSHalf Year 2023 Trading Update
23rd Mar 20232:33 pmRNSResult of AGM
23rd Mar 20237:00 amRNSAGM Trading Update
3rd Mar 20237:00 amRNSPosting of Annual Report and Notice of AGM
15th Feb 20237:00 amRNSExercise of Share Options & Total Voting Rights
9th Feb 202311:03 amRNSHolding(s) in Company
3rd Feb 20237:00 amRNSExercise of Share Options & Total Voting Rights
26th Jan 20237:00 amRNSFinal Results
11th Jan 20237:00 amRNSNotice of Final Results
15th Dec 20227:00 amRNSPayment of Earnout and Allotment of Shares
8th Dec 20221:17 pmRNSHolding(s) in Company
16th Nov 20227:00 amRNSTrading Statement
14th Nov 20227:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.